Patent classifications
C08G79/025
CROSSLINKED POLYPHOSPHAZENE BLENDS FOR GAS SEPARATION MEMBRANES
The disclosed invention relates to a composition comprising a crosslinked blend of polyphosphazene polymers. The composition comprises a first polyphosphazene and a second polyphosphazene, where the first polyphosphazene and the second polyphosphazene being bound by a thiol bearing crosslinking agent. Such compositions are useful as a membrane material for the separation of gasses in a gaseous mixture.
POLYMERS FOR GENE THERAPY
Polymers for gene therapy. The present invention relates to a polymer, more specifically a polyphosphazene polymer, that is useful for gene therapy. The invention also relates to a complex comprising the polymer, the method for producing same and uses thereof.
POLYMERS FOR GENE THERAPY
Polymers for gene therapy. The present invention relates to a polymer, more specifically a polyphosphazene polymer, that is useful for gene therapy. The invention also relates to a complex comprising the polymer, the method for producing same and uses thereof.
POLYPHOSPHAZENE AND MOLDING COMPOUND CONTAINING THE POLYPHOSPHAZENE
The invention relates to a polyphosphazene produced by a method comprising the steps a) and b): a) converting an in particular cyclical phosphazene by means of phenol in the presence of a base; b) further converting by means of a special aromatic diphenol in the presence of a base, wherein the molar ratio of phenol used to cyclical phosphazene used is in the range from 3.5:1 to 1:1. The invention also relates to a method for producing the polyphosphazene and to a molding compound containing the polyphosphazene and a thermoplastic polymer.
POLYPHOSPHAZENE AND MOLDING COMPOUND CONTAINING THE POLYPHOSPHAZENE
The invention relates to a polyphosphazene produced by a method comprising the steps a) and b): a) converting an in particular cyclical phosphazene by means of phenol in the presence of a base; b) further converting by means of a special aromatic diphenol in the presence of a base, wherein the molar ratio of phenol used to cyclical phosphazene used is in the range from 3.5:1 to 1:1. The invention also relates to a method for producing the polyphosphazene and to a molding compound containing the polyphosphazene and a thermoplastic polymer.
Touch sensitive device and display device including the same
Provided is a touch sensitive device including an electroactive layer formed of an electroactive matrix, wherein the electroactive matrix has a structure in which a piezoelectric ceramic and an electroactive polymer (EAP) are bonded and an electrode disposed on at least one surface of the electroactive layer. According to an exemplary embodiment of the present disclosure, the touch sensitive device uses an electroactive matrix has an excellent transparency, can be made thin, and has a high piezoelectric property so that the light transmittance and the vibration intensity of the touch sensitive device can be improved.
Touch sensitive device and display device including the same
Provided is a touch sensitive device including an electroactive layer formed of an electroactive matrix, wherein the electroactive matrix has a structure in which a piezoelectric ceramic and an electroactive polymer (EAP) are bonded and an electrode disposed on at least one surface of the electroactive layer. According to an exemplary embodiment of the present disclosure, the touch sensitive device uses an electroactive matrix has an excellent transparency, can be made thin, and has a high piezoelectric property so that the light transmittance and the vibration intensity of the touch sensitive device can be improved.
IN-SITU POLYPHOSPHAZENE GENERATION IN CEMENT FOR IMPROVED ELASTIC PROPERTIES
A composition of matter may include a cement precursor, a phosphazene oligomer and water. A method may include blending a phosphazene oligomer and a cement precursor to form a cement precursor mixture. The method may then include introducing water into the cement precursor mixture to form the cement slurry. A composition of matter may include a cured cement matrix having a polyphosphazene polymer distributed throughout the cement matrix. A method may include cementing a wellbore by introducing a cement slurry into a wellbore, where the cement slurry includes a phosphazene oligomer. The method then includes maintaining the cement slurry such that a cured cement sheath forms, the cement sheath having a polyphosphazene polymer.
IN-SITU POLYPHOSPHAZENE GENERATION IN CEMENT FOR IMPROVED ELASTIC PROPERTIES
A composition of matter may include a cement precursor, a phosphazene oligomer and water. A method may include blending a phosphazene oligomer and a cement precursor to form a cement precursor mixture. The method may then include introducing water into the cement precursor mixture to form the cement slurry. A composition of matter may include a cured cement matrix having a polyphosphazene polymer distributed throughout the cement matrix. A method may include cementing a wellbore by introducing a cement slurry into a wellbore, where the cement slurry includes a phosphazene oligomer. The method then includes maintaining the cement slurry such that a cured cement sheath forms, the cement sheath having a polyphosphazene polymer.
NOVEL CATIONIC POLYPHOSPHAZENE COMPOUND, POLYPHOSPHAZENES-DRUG CONJUGATE COMPOUND AND METHOD FOR PREPARING SAME
The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.